Open consultation

Statutory scheme to control costs of branded health service medicines

Summary

This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded health medicines.

This consultation closes at

Consultation description

In August 2018 the department consulted on proposed changes to the Branded Health Service Medicines (Costs) Regulations 2018. Some respondents asked for more information about:

  • the expected 2018 baseline for forecast relevant sales and allowed relevant sales
  • the calculation of the payment percentages for 2019 to 2021

The clarification note provides additional information about these issues to help respondents understand how the department calculated the proposed payment percentages.

Further comments are being invited on the proposed payment percentages and the methodology used in determining the payment percentages. Full details of how to submit further comments are provided in the clarification note.

Documents

2018 Statutory Scheme – Branded Medicines Pricing: impact assessment

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 7 August 2018
Last updated 5 October 2018 + show all updates
  1. Added clarification note to consultation page. This provides more information to help respondents understand how the department calculated the proposed payment percentages and invites further comments by 19 October 2018.
  2. First published.